SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Microcide Pharmaceuticals (MCDE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark Adams who wrote (134)2/1/1998 3:44:00 PM
From: John O'Neill  Read Replies (2) of 186
 
What will happen if antibiotic reistant bacteria are not stopped and
third wolrd countries act as breeding ground. How important would the issue be if TB, staff, etc. no longer could be treated with antibiotics??? 50 % of deaths prior to penicillin were caused by bacterial infections.

Are there other companies better positioned than MCDE to address this area..should we be in a different stock?

Is MCDE part of good portfolio or best play in this area? Cubist is there also.

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News